# Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes

> **NCT06116903** · NA · RECRUITING · sponsor: **University Hospital, Limoges** · enrollment: 60 (estimated)

## Conditions studied

- Glioma

## Interventions

- **GENETIC:** Blood sampling

## Key facts

- **NCT ID:** NCT06116903
- **Lead sponsor:** University Hospital, Limoges
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-11
- **Primary completion:** 2025-05-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2024-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06116903

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06116903, "Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT06116903. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*